International GMP Conference Bridges Science, Policy, and Partnerships

researchers at conference

The 49th International Good Manufacturing Practices (GMP) Conference held in March 2025 in Athens, Georgia, brought together more than 160 professionals from the pharmaceutical, regulatory, and academic sectors. Hosted by the University of Georgia (UGA) College of Pharmacy, a proud partner of the Georgia CTSA, the conference tackled urgent topics shaping the future of pharmaceutical quality and compliance—artificial intelligence, data integrity, compounding, and supply chain vulnerabilities. For many participants, the event was more than a professional milestone; as one attendee shared, “This conference is a cornerstone to my regulatory training objectives.” 

This year’s agenda reflected a growing urgency to adapt, collaborate, and innovate across the life sciences. Sessions explored everything from the evolution of AI in pharma to the intricacies of risk management in global supply chains. According to Georgia CTSA Regulatory Knowledge and Support leader Michael Bartlett, PhD, Associate Dean for Science Education, Research and Technology, UGA College of Pharmacy, the conference “represents an incredible intersection between the pharmaceutical and regulatory industries,” offering a rare opportunity to bring together “regulators and industry experts” under one roof to tackle real-world challenges. 

Speakers from across the globe—including representatives from Health Canada, U.S. Pharmacopeia (USP), Redica, AstraZeneca, Eli Lilly, and Parexel—shared regulatory insights, case studies, and forward-thinking strategies. Jerry Chapman and Mark Birse laid out the evolving landscape of AI’s role in quality systems. Galina Holloway and Jenny Liu (USP) addressed excipient testing and contamination prevention, while Magda Joseph (Health Canada) shared practical inspection case studies. The agenda also featured engaging panels on data integrity, supply chain risks, and real-world evidence in decision-making. 

The conference wasn’t limited to lectures. Through dynamic Q&A panels, open mic sessions, and hands-on workshops, participants were encouraged to explore ideas and exchange practical solutions. Topics like quality risk management, CMC dossier preparation, and global regulatory alignment added hands-on relevance for professionals navigating complex compliance landscapes. 

Evening sessions pushed the boundaries of science and imagination. UGA’s own Dr. Henry F. Schaefer III delivered a thought-provoking keynote on quantum computing, expanding the conversation beyond immediate industry challenges and into what lies ahead. 

For many, the greatest value was in the connections. “Meeting people who shared valuable insights and perspectives that I know will be helpful in my career was a highlight,” one participant noted. Others praised the structure, flow, and atmosphere of the event. “The sessions were insightful, and I really enjoyed the discussions and networking opportunities.” 

For Georgia CTSA, the GMP Conference is a shining example of how local institutions can fuel global impact. It reflects the alliance’s mission to foster meaningful collaboration across academic, industry, and regulatory boundaries—accelerating the translation of research into real-world health solutions. 

As the conference continues to evolve, Georgia CTSA proudly celebrates UGA’s leadership in organizing this globally respected event and looks forward to its ongoing contributions to advancing pharmaceutical excellence, policy, and public health outcomes.